Gliclavac MV 0.3mg/500mg/80mg Tablet
Marketer
Prevego Healthcare & Research Private Limited
Salt Composition
Voglibose (0.3mg) + Metformin (500mg) + Gliclazide (80mg)
Overview Gliclavac MV 0.3mg/500mg/80mg Tablet
Diabetic patients using Gliclavac MV 0.3mg/500mg/80mg tablets, classified as an antidiabetic combination medication, should adhere to prescribed dosages for effective type 2 diabetes mellitus management in adults. This medication regulates blood glucose, administered with food at consistent intervals for optimal results. Dosage adjustments are determined by your physician based on blood sugar monitoring. Continuous use, even with controlled glucose levels, is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive treatment plan including diet, exercise, and weight management as directed by your doctor. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential for prevention. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional possible side effects include altered taste perception, nausea, vomiting, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and weight gain. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should consult their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood sugar monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.
Uses of Gliclavac MV 0.3mg/500mg/80mg Tablet
Managing type 2 diabetes
Major Benefits of Gliclavac MV 0.3mg/500mg/80mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gliclavac MV 0.3mg/500mg/80mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Gliclavac MV 0.3mg/500mg/80mg Tablet:
- Nausea
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Constipation
How to use Gliclavac MV 0.3mg/500mg/80mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gliclavac MV 0.3mg/500mg/80mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Gliclavac MV 0.3mg/500mg/80mg Tablet works:
Each Gliclavac MV 0.3mg/500mg/80mg tablet contains a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gliclavac MV 0.3mg/500mg/80mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Gliclavac MV 0.3mg/500mg/80mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks before prescribing this medication. Consult your doctor for advice.
Breast feedingCAUTION
The use of Gliclavac MV 0.3mg/500mg/80mg tablets necessitates prudence while breastfeeding. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Gliclavac MV 0.3mg/500mg/80mg tablets cautiously, potentially requiring dose modification. Physician consultation is advised. Gliclavac MV 0.3mg/500mg/80mg tablets are contraindicated in those with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Gliclavac MV 0.3mg/500mg/80mg tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease may begin with a reduced dose; however, its use is contraindicated in those with severe liver disease. Medical advice is essential.
What if you forget to take Gliclavac MV 0.3mg/500mg/80mg Tablet :
NA
Facts to Know About Gliclavac MV 0.3mg/500mg/80mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently